Temasek result gives a window into sovereign wealth strategy through Covid
Euromoney, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Temasek result gives a window into sovereign wealth strategy through Covid

The Singaporean investment company made a loss – but an impressive one in the circumstances.

Chris Wright on Asia 1920px.jpg

Temasek, one of Singapore’s sovereign wealth vehicles, today announced unaudited figures for its last financial year, showing a 2.3% decline in total shareholder return.

In the circumstances, that’s really not bad.

The Temasek financial year ends on March 31 – which, you’ll recall, was right in the teeth of the market declines as Covid escalated from being an Asian to a truly global concern. The World Health Organization declared Covid-19 a pandemic on March 11; the market bottom, for now at least, came 12 days later, and the Temasek year-end eight days after that.

The MSCI World Index was down 5.8% in the year to March 31, the MSCI AC Asia ex-Japan 9% and the MSCI Singapore Index 18.3%.

Temasek’s success in ducking most of this loss, and maintaining a compound total shareholder return of 7.5% annualized over the last 16 years (or 14% a year since foundation in 1974), shows the nimbleness of a unique sovereign institution.

We’ve remarked before that Temasek does not look like most other sovereign wealth funds. The vehicle in Singapore with the classic sovereign wealth appearance – balanced portfolio across multiple asset classes, mandate to invest and diversify the national reserves, target to beat inflation – is GIC.

Gift this article